A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19-65

SponsorAhn-Gook Pharmaceuticals Co.,Ltd

About this trial

The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.

A healthy adults aged 19-65 years at the time of screening

Subjects who are deemed eligible based on the screening tests

Subjects who have taken the investigational drug within 6 months prior to the first dose

Other exclusions have been applied

70 Participants

are divided into 2 treatment groups

This trial has no locations

Ahn-Gook Pharmaceuticals Co.,Ltd

Lead sponsor